Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) were down 25.7% during mid-day trading on Friday . The stock traded as low as $0.30 and last traded at $0.30. Approximately 5,501 shares were traded during mid-day trading, an increase of 18% from the average daily volume of 4,647 shares. The stock had previously closed at $0.40.
bioAffinity Technologies Stock Performance
The stock has a 50-day moving average of $0.74 and a 200-day moving average of $0.85.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
See Also
- Five stocks we like better than bioAffinity Technologies
- Stock Sentiment Analysis: How it Works
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to trade using analyst ratings
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is the Euro STOXX 50 Index?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
